Home » Topics » BioWorld Science

BioWorld Science
RSS

Deciphera Pharmaceuticals presents new clinical data for ripretinib in patients with GIST

Aug. 13, 2019

Interim data from phase Ib study of KPL-716 supports phase II development

Aug. 13, 2019

Study finds best tools for pinpointing genetic disease drivers

Aug. 13, 2019

Basilea initiates phase I/II FIDES-02 study of derazantinib in urothelial cancer

Aug. 13, 2019

Oncologie and Merck & Co. to test bavituximab plus Keytruda in gastric cancer

Aug. 13, 2019

TR-FRET-based screening identifies novel CBP bromodomain inhibitor with therapeutic potential

Aug. 13, 2019

PALM Ebola study stopped early due to favorable results for two of four candidates

Aug. 13, 2019

FDA grants accelerated approval for bedaquiline in adolescents with MDR-TB

Aug. 13, 2019

Inhibition of mitoNEET shows antileukemic activity in drug-resistant cells and in vivo models

Aug. 13, 2019

Mu-opioid receptor agonists discovered at Sichuan Kelun-Biotech Biopharmaceutical

Aug. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...